REVA Medical Inc (RVA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It offers fantom, a bioresorbable vascular scaffold developed as an alternative to metallic stents for the treatment of coronary artery disease. It also develops proprietary polymers for scaffold performance. The companys fantom supports the artery through the healing process providing restoration of blood flow. It operates in Australia, Brazil and New Zealand, among others. REVA is headquartered in San Diego, California, the US.

REVA Medical Inc (RVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
REVA Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
REVA Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
REVA Medical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
REVA Medical to Raise USD8.2 Million in Private Placement of Shares 11
Reva Medical Mulls for US IPO 12
Debt Offering 13
REVA Medical Raises USD13.3 Million in Second Tranche of Private Placement of 8% Notes Due 2022 13
REVA Medical Raises USD21.3 Million in First Tranche of Private Placement of 8% Notes Due 2022 14
REVA Medical Inc - Key Competitors 15
REVA Medical Inc - Key Employees 16
REVA Medical Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
May 09, 2018: Reva Medical Announces First Quarter 2018 Financial Results 18
Mar 08, 2018: REVA Medical Reports Fourth Quarter and Full Year 2017 Financial Results 20
Nov 07, 2017: REVA Medical Reports Third Quarter 2017 Financial Results 22
Aug 10, 2017: REVA Medical: Half-Yearly Report 24
Jul 31, 2017: REVA Medical: Quarter Ended 30 June 2017 26
Corporate Communications 27
Feb 05, 2018: Reva Appoints Stephen Oesterle As Board Of Directors 27
Sep 20, 2017: Reva Announces Ray Larkin Jr. as Chairman ofthe Board of Directors 28
Sep 01, 2017: REVA Appoints Brandi Roberts as Chief Financial Officer and Company Secretary 29
Jul 13, 2017: REVA Medical Announces Organizational Changes 30
Jun 09, 2017: REVA Medical: Changes to Board of Directors 31
Other Significant Developments 32
Feb 01, 2018: REVA Medical: Quarter Ended 31 December 2017 32
Jan 31, 2017: REVA Medical: Quarter Ended 31 December 2016 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables

List of Tables
REVA Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
REVA Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
REVA Medical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
REVA Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
REVA Medical to Raise USD8.2 Million in Private Placement of Shares 11
Reva Medical Mulls for US IPO 12
REVA Medical Raises USD13.3 Million in Second Tranche of Private Placement of 8% Notes Due 2022 13
REVA Medical Raises USD21.3 Million in First Tranche of Private Placement of 8% Notes Due 2022 14
REVA Medical Inc, Key Competitors 15
REVA Medical Inc, Key Employees 16
REVA Medical Inc, Subsidiaries 17

List Of Figures

List of Figures
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
REVA Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
REVA Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9

Cerevance Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cerevance Inc (Cerevance) is a pharmaceutical company that strives to develop medicines for the treatment of neurological and psychiatric diseases. It is also developing preclinical and clinical programs for Parkinsons

USD 250 View Report

Revalesio Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Revalesio Corp (Revalesio) is a developer of novel therapeutics for the treatment of inflammatory diseases. The company conducts research and development activities to develop therapeutics in the areas of respiratory,

USD 250 View Report

Aethlon Medical Inc (AEMD) - Product Pipeline Analysis, 2019 Update

Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. The companys lead product Hemopurifier is a clinical-stage immunotherapeutic device

USD 750 View Report

Natus Medical Incorporated (NTUS) - Financial and Strategic SWOT Analysis Review

Natus Medical Incorporated (NTUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available